Literature DB >> 16373655

Lessons from nosocomial viral haemorrhagic fever outbreaks.

Susan P Fisher-Hoch1.   

Abstract

The outbreak of Marburg haemorrhagic fever in Angola in 2004-2005 shows once again the devastating and rapid spread of viral haemorrhagic fevers in medical settings where hygiene practices are poorly applied or ignored. The legacy of years of war and poverty in Angola has resulted in very poor medical education and services. The initial high rate of infection among infants in Angola may have been related to poor hospital practices, possibly administration of vaccines. Though the outbreak in Angola was in a part of Africa not previously known to have filovirus infection, prior ecological modelling had predicted this location and many others. Prevention of future outbreaks will not be easy. The urgent need is dissemination of knowledge and the training, discipline and resources for good clinical practice. Educating the public to demand higher standards could be a powerful tool. Good practices are difficult to establish and maintain on the scale needed.

Entities:  

Mesh:

Year:  2005        PMID: 16373655     DOI: 10.1093/bmb/ldh054

Source DB:  PubMed          Journal:  Br Med Bull        ISSN: 0007-1420            Impact factor:   4.291


  24 in total

1.  Evaluation of perceived threat differences posed by filovirus variants.

Authors:  Jens H Kuhn; Lori E Dodd; Victoria Wahl-Jensen; Sheli R Radoshitzky; Sina Bavari; Peter B Jahrling
Journal:  Biosecur Bioterror       Date:  2011-11-09

2.  Validation of the efficacy of a solar-thermal powered autoclave system for off-grid medical instrument wet sterilization.

Authors:  Tremayne Kaseman; Jean Boubour; Douglas A Schuler
Journal:  Am J Trop Med Hyg       Date:  2012-07-30       Impact factor: 2.345

3.  Filovirus emergence and vaccine development: a perspective for health care practitioners in travel medicine.

Authors:  Uzma N Sarwar; Sandra Sitar; Julie E Ledgerwood
Journal:  Travel Med Infect Dis       Date:  2010-06-26       Impact factor: 6.211

4.  Detection of infectious disease outbreaks in twenty-two fragile states, 2000-2010: a systematic review.

Authors:  Catherine Bruckner; Francesco Checchi
Journal:  Confl Health       Date:  2011-08-23       Impact factor: 2.723

5.  Seroepidemiological survey of Crimean-Congo hemorrhagic fever among sheep in Mazandaran province, northern Iran.

Authors:  Ehsan Mostafavi; Sadegh Chinikar; Saber Esmaeili; Fahimeh Bagheri Amiri; Amir Mohammad Ali Tabrizi; Sahar KhakiFirouz
Journal:  Vector Borne Zoonotic Dis       Date:  2012-08-23       Impact factor: 2.133

6.  Constraints in the diagnosis and treatment of Lassa Fever and the effect on mortality in hospitalized children and women with obstetric conditions in a rural district hospital in Sierra Leone.

Authors:  A Dahmane; J van Griensven; M Van Herp; R Van den Bergh; Y Nzomukunda; J Prior; P Alders; A Jambai; R Zachariah
Journal:  Trans R Soc Trop Med Hyg       Date:  2014-03       Impact factor: 2.184

7.  Infection control during filoviral hemorrhagic Fever outbreaks.

Authors:  Vanessa N Raabea; Matthias Borcherta
Journal:  J Glob Infect Dis       Date:  2012-01

8.  Prevalence and risk factors of Lassa seropositivity in inhabitants of the forest region of Guinea: a cross-sectional study.

Authors:  Solen Kernéis; Lamine Koivogui; N'Faly Magassouba; Kekoura Koulemou; Rosamund Lewis; Aristide Aplogan; Rebecca F Grais; Philippe J Guerin; Elisabeth Fichet-Calvet
Journal:  PLoS Negl Trop Dis       Date:  2009-11-17

Review 9.  Vaccination strategies against highly pathogenic arenaviruses: the next steps toward clinical trials.

Authors:  Stephan Olschläger; Lukas Flatz
Journal:  PLoS Pathog       Date:  2013-04-11       Impact factor: 6.823

Review 10.  Guidance for contact tracing of cases of Lassa fever, Ebola or Marburg haemorrhagic fever on an airplane: results of a European expert consultation.

Authors:  Andreas Gilsdorf; Dilys Morgan; Katrin Leitmeyer
Journal:  BMC Public Health       Date:  2012-11-21       Impact factor: 3.295

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.